Clinical chorioamnionitis at term VI: Acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity

Journal of Perinatal Medicine

Volumn 44, Issue 1, 2016, Pages 33-51

  Romero, Roberto ^a,b,c,d   Chaemsaithong, Piya ^a,e   Docheva, Nikolina ^a,e   Korzeniewski, Steven J ^a,c,e   Kusanovic, Juan P ^a,f,g   Yoon, Bo Hyun ^a,h   Kim, Jung Sun ^a,i   Chaiyasit, Noppadol ^a,i   Ahmed, Ahmed I ^a,i   Qureshi, Faisal ^a,j   Jacques, Suzanne M ^a,j   Kim, Chong Jai ^a,k   Hassan, Sonia S ^a,e   Chaiworapongsa, Tinnakorn ^a,e   Yeo, Lami ^a,e   Kim, Yeon Mee ^a,l  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^h Seoul National University   (South Korea)

ⁱ Sungkyunkwan University   (South Korea)

^j HARPER UNIVERSITY HOSPITAL   (United States)

^k University of Ulsan College of Medicine   (South Korea)

^l Inje University College of Medicine   (South Korea)

more..

Author keywords

Acute histologic chorioamnionitis; fetal inflammatory response syndrome (FIRS); interleukin 6 (IL 6); microbial associated intra amniotic inflammation; neonatal sepsis

Indexed keywords

INTERLEUKIN 6; AUTACOID; IL6 PROTEIN, HUMAN;

ADVERSE OUTCOME; AMNIOCENTESIS; AMNIONITIS; ARTICLE; CHORIOAMNIONITIS; CLINICAL ARTICLE; CLINICAL CHORIOAMNIONITIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL INFLAMMATORY RESPONSE SYNDROME; FETUS; FUNISITIS; HUMAN; HUMAN TISSUE; MICROBIAL ASSOCIATED INTRA AMNIOTIC INFLAMMATION; OUTCOME ASSESSMENT; PLACENTA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; AMNION FLUID; FETAL DISEASES; IMMUNOLOGY; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; PATHOLOGY; PREGNANCY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AMNIOTIC FLUID; CHORIOAMNIONITIS; COHORT STUDIES; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICROBIOLOGICAL TECHNIQUES; PLACENTA; PREGNANCY; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84955315719     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2015-0119     Document Type: Article

References (270)

1. Romero R, Miranda J, Kusanovic JP, Chaiworapongsa T, Chaemsaithong P, Martinez A, et al. Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques. J Perinat Med. 2015;43:19-36.
2. Gibbs RS. Diagnosis of intra-Amniotic infection. Semin Perinatol. 1977;1:71-7.
3. Romero R, Chaemsaithong P, Korzeniewski SJ, Kusanovic JP, Docheva N, Martinez-Varea A, et al. Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-Amniotic infection?. J Perinat Med. 2016;44:23-32.
4. Gibbs RS, Castillo MS, Rodgers PJ. Management of acute chorioamnionitis. Am J Obstet Gynecol. 1980;136:709-13.
5. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982;145:1-8.
6. MacVicar J. Chorioamnionitis. Clin Obstet Gynecol. 1970;13:272-90.
7. Hollander D. Diagnosis of chorioamnionitis. Clin Obstet Gynecol. 1986;29:816-25.
8. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol. 1993;36:795-808.
9. Romero R, Chaemsaithong P, Korzeniewski SJ, Tarca AL, Bhatti G, Xu Z, et al. Clinical chorioamnionitis at term II: the intra-Amniotic inflammatory response. J Perinat Med. 2016;44:5-22.
10. Romero R, Chaemsaithong P, Docheva N, Korzeniewski SJ, Tarca AL, Bhatti G, et al. Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile. J Perinat Med. 2016;44:77-98.
11. Romero R, Chaemsaithoing P, Docheva N, Korzeniewski SJ, Tarca AL, Bhatti G, et al. Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response. J Perinat Med. 2016;44:53-76.
12. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37:339-54.
13. Romero R, Chaiworapongsa T, Savasan ZA, Hussein Y, Dong Z, Kusanovic JP, et al. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med. 2012;25:558-67.
14. Fishman SG, Gelber SE. Evidence for the clinical management of chorioamnionitis. Semin Fetal & Neonatal Medicine 2012;17:46-50.
15. Yoder PR, Gibbs RS, Blanco JD, Castaneda YS, St Clair PJ. A prospective, controlled study of maternal and perinatal outcome after intra-Amniotic infection at term. Am J Obstet Gynecol. 1983;145:695-701.
16. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis. Obstet Gynecol. 1996;87:188-94.
17. Ladfors L, Tessin I, Mattsson LA, Eriksson M, Seeberg S, Fall O. Risk factors for neonatal sepsis in offspring of women with prelabor rupture of the membranes at 34-42 weeks. J Perinat Med. 1998;26:94-101.
18. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol. 1999;94:274-8.
19. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103:e77.
20. Volante E, Moretti S, Pisani F, Bevilacqua G. Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med. 2004;16(Suppl 2):13-6.
21. Rouse DJ, Landon M, Leveno KJ, Leindecker S, Varner MW, Caritis SN, et al. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol. 2004;191:211-6.
22. Uyemura A, Ameel B, Caughey A. 425. Outcomes of chorioamnionitis in term pregnancies. Am J Obstet Gynecol. 2014;210:S215.
23. Pappas A, Kendrick DE, Shankaran S, Stoll BJ, Bell EF, Laptook AR, et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-Age neonates. J Am Med Assoc Pediatr. 2014;168:137-47.
24. Qazi SA, Stoll BJ. Neonatal sepsis: a major global public health challenge. Pediatr infect Dis J. 2009;28(Suppl 1):S1-2.
25. Ganatra HA, Stoll BJ, Zaidi AK. International perspective on early-onset neonatal sepsis. Clin Perinatol. 2010;37:501-23.
26. Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006-15.
27. Puopolo KM. Response to the American Academy of Pediatrics, Committee on the Fetus and Newborn statement, management of neonates with suspected or proven early-onset bacterial sepsis . Pediatrics. 2012;130:e1054-5; author reply e5-7.
28. Polin R. In reply, clinical report: management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;130:e1055-7.
29. Bhatti M, Chu A, Hageman JR, Schreiber M, Alexander K. Future directions in the evaluation and management of neonatal sepsis. NeoReviews. 2012;13:e103-E10.
30. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60:367-89.
31. Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics. 2013;132:166-8.
32. Polin RA, Watterberg K, Benitz W, Eichenwald E. The conundrum of early-onset sepsis. Pediatrics. 2014;133:1122-3.
33. Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infection. 2014;68(Suppl 1):S24-32.
34. Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr. 2015;166:1070-4.
35. Romero R, Miranda J, Chaemsaithong P, Chaiworapongsa T, Kusanovic JP, Dong Z, et al. Sterile and microbial-Associated intra-Amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2014:1-16. [Epub ahead of print].
36. Romero R, Miranda J, Chaiworapongsa T, Chaemsaithong P, Gotsch F, Dong Z, et al. A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-Amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol. 2014;71:330-58.
37. Romero R, Miranda J, Chaiworapongsa T, Chaemsaithong P, Gotsch F, Dong Z, et al. Sterile intra-Amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J Matern Fetal Neonatal Med. 2014:1-17. [Epub ahead of print].
38. Romero R, Kadar N, Miranda J, Korzeniewski SJ, Schwartz AG, Chaemsaithong P, et al. The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-Amniotic inflammation is not superior to amniotic fluid interleukin-6. J Matern Fetal Neonatal Med. 2014;27:757-69.
39. Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, et al. Prevalence and clinical significance of sterile intra-Amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014;72:458-74.
40. Yoon BH, Romero R, Kim M, Kim EC, Kim T, Park JS, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol. 2000;183:1130-7.
41. Yoon BH, Romero R, Moon J, Chaiworapongsa T, Espinoza J, Kim YM, et al. Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation. J Matern Fetal Neonatal Med. 2003;13:32-8.
42. Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Nikolaitchouk N, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand. 2003;82:423-31.
43. Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Wennerholm UB, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet Gynecol Scand. 2003;82:120-8.
44. Kim M, Kim G, Romero R, Shim SS, Kim EC, Yoon BH. Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J Perinat Med. 2003;31:146-52.
45. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culturebased investigation. PloS one. 2008;3:e3056.
46. DiGiulio DB, Romero R, Kusanovic JP, Gomez R, Kim CJ, Seok KS, et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol. 2010;64:38-57.
47. DiGiulio DB, Gervasi M, Romero R, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, et al. Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods. J Perinat Med. 2010;38:503-13.
48. Kacerovsky M, Celec P, Vlkova B, Skogstrand K, Hougaard DM, Cobo T, et al. Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria. PloS one. 2013;8:e60399.
49. Cobo T, Kacerovsky M, Jacobsson B. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014;211:708.
50. Kacerovsky M, Musilova I, Andrys C, Hornychova H, Pliskova L, Kostal M, et al. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am J Obstet Gynecol. 2014;210:325 e1-E10.
51. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760-5.
52. Allen-Daniels MJ, Serrano MG, Pflugner LP, Fettweis JM, Prestosa MA, Koparde VN, et al. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. Am J Obstet Gynecol. 2015. [Epub ahead of print].
53. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, et al. Clinical significance of intra-Amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2001;185:1130-6.
54. Romero R, Chaiworapongsa T, Alpay Savasan Z, Xu Y, Hussein Y, Dong Z, et al. Damage-Associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med. 2011;24:1444-55.
55. Cobo T, Palacio M, Martinez-Terron M, Navarro-Sastre A, Bosch J, Filella X, et al. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obstet Gynecol. 2011;205:126 e1-8.
56. Chaemsaithong P, Romero R, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS, et al. A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10. J Matern Fetal Neonatal Med. 2014:1-10.
57. Combs CA, Gravett M, Garite TJ, Hickok DE, Lapidus J, Porreco R, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014;210:125. e1-15.
58. Chaemsaithong P, Romero R, Korzeniewski SJ, Dong Z, Martinez-Varea A, Yoon BH, et al. A Rapid interleukin-6 bedside test for the identification of intra-Amniotic inflammation in preterm labor with intact membranes. J Matern Fetal Neonatal Med. 2015;23:1-11. [Epub ahead of print].
59. Chaemsaithong P, Romero R, Korzeniewski SJ, Dong Z, Martinez-Varea A, Yoon BH, et al. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membrances: a step toward the early treatment of acute intraamniotic inflammation/infection. J Matern Fetal Neonatal Med. 2015;23:1-8. [Epub ahead of print].
60. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC, Prevention. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 2010;59(RR-10):1-6.
61. Tollner U, Pohlandt F, Kleinhauer E. Neonatal infection and white blood cell count. Pediatrics. 1980;65:1196-7.
62. Philip AG. White blood cells and acute phase reactants in neonatal sepsis. Pediatrie. 1984;39:371-8.
63. Weinberg AG, Rosenfeld CR, Manroe BL, Browne R. Neonatal blood cell count in health and disease. II. Values for lymphocytes, monocytes, and eosinophils. J Pediatr. 1985;106:462-6.
64. Rozycki HJ, Stahl GE, Baumgart S. Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis. Pediatr Infect Dis J. 1987;6:440-2.
65. Kumar A. Leukocyte studies in diagnosis of neonatal sepsis. J Pediatr. 1989;114:505-6.
66. Greenberg DN, Yoder BA. Changes in the differential white blood cell count in screening for group B streptococcal sepsis. Pediatr Infect Dis J. 1990;9:886-9.
67. DaSilva O, Hammerberg O. Diagnostic value of leukocyte indices in late neonatal sepsis. Pediatr Infect Dis J. 1994;13:409-11.
68. Berger C, Uehlinger J, Ghelfi D, Blau N, Fanconi S. Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicaemia. Eur J Pediatr. 1995;154:138-44.
69. Buck C, Pohlandt F. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal infection. Pediatr Infect Dis Journal. 1995;14:1119-20.
70. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis Journal. 1995;14:362-6.
71. Polinski C. The value of the white blood cell count and differential in the prediction of neonatal sepsis. Neonatal Network. 1996;15:13-23.
72. da Silva O, Ohlsson A. How accurate are leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis?. Paediatr Child Health. 1998;3:158-9.
73. Faix RG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at-risk newborn. J Pediatr. 2003;143:686-7.
74. Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J. 2003;22:430-4.
75. Hornik CP, Benjamin DK, Becker KC, Benjamin DK, Jr., Li J, Clark RH, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:803-7.
76. Resch B, Edlinger S, Muller W. White blood cell counts in neonatal early-onset sepsis. Pediatr Infect Dis J. 2012;31:540-1; author reply 1.
77. Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:16-9.
78. Mussap M. Laboratory medicine in neonatal sepsis and inflammation. J Matern Fetal Neonatal Med. 2012;25(Suppl 4): 32-4.
79. Hornik CP, Benjamin DK, Becker KC, Benjamin DK, Jr., Li J, Clark RH, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:799-802.
80. Makkar M, Gupta C, Pathak R, Garg S, Mahajan NC. Performance evaluation of hematologic scoring system in early diagnosis of neonatal sepsis. J Clin Neonat. 2013;2:25-9.
81. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal. 2004;89:F229-35.
82. Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence. 2014;5:170-8.
83. Soni S, Wadhwa N, Kumar R, Faridi MM. Use of immature-Tototal-neutrophil ratio in early neonatal sepsis. Pediatr Infect Dis J. 2012;31:1101-2; author reply 2.
84. Miller LC, Isa S, LoPreste G, Schaller JG, Dinarello CA. Neonatal interleukin-1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J Pediatr. 1990;117:961-5.
85. Buck C, Bundschu J, Gallati H, Bartmann P, Pohlandt F. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics. 1994;93:54-8.
86. Lehrnbecher T, Schrod L, Kraus D, Roos T, Martius J, von Stockhausen HB. Interleukin-6 and soluble interleukin-6 receptor in cord blood in the diagnosis of early onset sepsis in neonates. Acta Paediatrica. 1995;84:806-8.
87. Lehrnbecher T, Schrod L, Rutsch P, Roos T, Martius J, von Stockhausen HB. Immunologic parameters in cord blood indicating early-onset sepsis. Biol Neonate. 1996;70:206-12.
88. Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr. 1996;129:574-80.
89. Singh B, Merchant P, Walker CR, Kryworuchko M, Diaz-Mitoma F. Interleukin-6 expression in cord blood of patients with clinical chorioamnionitis. Pediat Res. 1996;39:976-9.
90. Smulian JC, Bhandari V, Campbell WA, Rodis JF, Vintzileos AM. Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis. J Maternal Fetal Med. 1997;6:254-9.
91. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, et al. Plasma levels and gene expression of granulocyte colonystimulating factor, tumor necrosis factor-Alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res. 1998;44:469-77.
92. Weimann E, Rutkowski S, Reisbach G. G-CSF, GM-CSF and IL-6 levels in cord blood: diminished increase of G-CSF and IL-6 in preterms with perinatal infection compared to term neonates. J Perinat Med. 1998;26:211-8.
93. Perenyi A, Johann-Liang R, Stavola JJ. Assessment of cord blood IL-6 levels as an indicator of neonatal sepsis. Am J Perinat. 1999;16:525-30.
94. Smulian JC, Vintzileos AM, Lai YL, Santiago J, Shen-Schwarz S, Campbell WA. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J matern Fetal Med. 1999;8:88-94.
95. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-Alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatrica. 1999;88:647-50.
96. Kashlan F, Smulian J, Shen-Schwarz S, Anwar M, Hiatt M, Hegyi T. Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. The Pediatr Infect Dis J. 2000;19:238-43.
97. Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. The Pediatr Infect Dis J. 2000;19:879-87.
98. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000;183:1124-9.
99. Dollner H, Vatten L, Linnebo I, Zanussi GF, Laerdal A, Austgulen R. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate. 2001;80:41-7.
100. Krueger M, Nauck MS, Sang S, Hentschel R, Wieland H, Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate. 2001;80:118-23.
101. Santana C, Guindeo MC, Gonzalez G, Garcia-Munoz F, Saavedra P, Domenech E. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatrica. 2001;90:1176-81.
102. Dollner H, Vatten L, Halgunset J, Rahimipoor S, Austgulen R. Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. BJOG Int J Obstet Gynaec. 2002;109:534-9.
103. Laborada G, Rego M, Jain A, Guliano M, Stavola J, Ballabh P, et al. Diagnostic value of cytokines and C-reactive protein in the first 24 hours of neonatal sepsis. Am Journal Perinat. 2003;20:491-501.
104. Santana Reyes C, Garcia-Munoz F, Reyes D, Gonzalez G, Dominguez C, Domenech E. Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-Alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatrica. 2003;92:221-7.
105. Hatzidaki E, Gourgiotis D, Manoura A, Korakaki E, Bossios A, Galanakis E, et al. Interleukin-6 in preterm premature rupture of membranes as an indicator of neonatal outcome. Acta Obstet Gynecol Scand. 2005;84:632-8.
106. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr. 2006;18:125-31.
107. Tasci Y, Dilbaz B, Uzmez Onal B, Caliskan E, Dilbaz S, Doganci L, et al. The value of cord blood interleukin-6 levels for predicting chorioamnionitis, funisitis and neonatal infection in term premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2006;128:34-9.
108. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis. 2008;21:223-7.
109. Veleminsky M, Jr., Stransky P, Veleminsky M, Sr., Tosner J. Relationship of IL-6, IL-8, TNF and sICAM-1 levels to PROM, pPROM, and the risk of early-onset neonatal sepsis. Neuroendocrinol Lett. 2008;29:303-11.
110. Prinsen JH, Baranski E, Posch H, Tober K, Gerstmeyer A. Interleukin-6 as diagnostic marker for neonatal sepsis: determination of Access IL-6 cutoff for newborns. Clin Lab. 2008;54:179-83.
111. Cancelier AC, Petronilho F, Reinke A, Constantino L, Machado R, Ritter C, et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: a case-control study. Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2009;10:467-71.
112. Cernada M, Badia N, Modesto V, Alonso R, Mejias A, Golombek S, et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatrica. 2012;101:e203-7.
113. Fan Y, Yu JL. Umbilical blood biomarkers for predicting earlyonset neonatal sepsis. World J Pediatr. 2012;8:101-8.
114. Hassanein SM, El-Farrash RA, Hafez HM, Hassanin OM, Abd El Rahman NA. Cord blood interleukin-6 and neonatal morbidities among preterm infants with PCR-positive Ureaplasma urealyticum. J Matern Fetal Neonatal Med. 2012;25:2106-10.
115. Cobo T, Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, et al. Umbilical cord blood IL-6 as predictor of early-onset neonatal sepsis in women with preterm prelabour rupture of membranes. PloS one. 2013;8:e69341.
116. Prashant A, Vishwanath P, Kulkarni P, Sathya Narayana P, Gowdara V, Nataraj SM, et al. Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-A case control study. PloS one. 2013;8:e68426.
117. Sorokin Y, Romero R, Mele L, Iams JD, Peaceman AM, Leveno KJ, et al. Umbilical cord serum interleukin-6, C-reactive protein, and myeloperoxidase concentrations at birth and association with neonatal morbidities and long-Term neurodevelopmental outcomes. Am J Perinat. 2014;31:717-26.
118. Su H, Chang SS, Han CM, Wu KY, Li MC, Huang CY, et al. Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-A systemic review and meta-Analysis. J Perinat: Official J California Perinatal Association. 2014;34:268-74.
119. Berner R, Tuxen B, Clad A, Forster J, Brandis M. Elevated gene expression of interleukin-8 in cord blood is a sensitive marker for neonatal infection. Eur J Pediat. 2000;159:205-10.
120. Sabel KG, Wadsworth C. C-reactive protein (CRP) in early diagnosis of neonatal septicemia. Acta Paediatrica Scand. 1979;68:825-31.
121. Hindocha P, Campbell CA, Gould JD, Wojciechowski A, Wood CB. Serial study of C reactive protein in neonatal septicaemia. Arch Dis Child. 1984;59:435-8.
122. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonat. 2006;91:F208-12.
123. Joram N, Boscher C, Denizot S, Loubersac V, Winer N, Roze JC, et al. Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonat. 2006;91:F65-6.
124. Kordek A, Halasa M, Podraza W. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin Chem Lab Med. 2008;46:1143-8.
125. Howman RA, Charles AK, Jacques A, Doherty DA, Simmer K, Strunk T, et al. Inflammatory and haematological markers in the maternal, umbilical cord and infant circulation in histological chorioamnionitis. PloS one. 2012;7:e51836.
126. Janota J, Stranak Z, Belohlavkova S, Mudra K, Simak J. Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Eur J Clin Invest. 2001;31:978-83.
127. Kordek A, Giedrys-Kalemba S, Pawlus B, Podraza W, Czajka R. Umbilical cord blood serum procalcitonin concentration in the diagnosis of early neonatal infection. J Perinat: Official J California Perinatal Association. 2003;23:148-53.
128. Llorente E, Prieto B, Cardo L, Avello N, Alvarez FV. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis. Clin Chem Lab Med. 2007;45:1531-5.
129. Dietzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemia-bacterial counts in blood. J Pediat. 1974;85:128-30.
130. Polin JI, Knox I, Baumgart S, Campman E, Mennuti MT, Polin RA. Use of umbilical cord blood culture for detection of neonatal bacteremia. Obstet Gynecol. 1981;57:233-7.
131. Neal PR, Kleiman MB, Reynolds JK, Allen SD, Lemons JA, Yu PL. Volume of blood submitted for culture from neonates. J Clin Microbiol. 1986;24:353-6.
132. Kellogg JA, Ferrentino FL, Goodstein MH, Liss J, Shapiro SL, Bankert DA. Frequency of low level bacteremia in infants from birth to two months of age. Pediat Infect Dis J. 1997;16: 381-5.
133. Polin RA. The ins and outs of neonatal sepsis. J Pediatr. 2003;143:3-4.
134. Connell TG, Rele M, Cowley D, Buttery JP, Curtis N. How reliable is a negative blood culture result?. Volume of blood submitted for culture in routine practice in a children s hospital. Pediatrics. 2007;119:891-6.
135. Hendricks-Munoz KD, Shapiro DL. The role of the lumbar puncture in the admission sepsis evaluation of the premature infant. J Perinat: Official J California Perinatal Association. 1990;10:60-4.
136. Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed?. Pediatrics. 1995;95:803-6.
137. Kumar P, Sarkar S, Narang A. Role of routine lumbar puncture in neonatal sepsis. J Paediatr Child H. 1995;31:8-10.
138. McIntyre P, Isaacs D. Lumbar puncture in suspected neonatal sepsis. J Paediatr Child H. 1995;31:1-2.
139. Beeram M, Oltorf C, Cipriani C. Lumbar puncture in the evaluation for early neonatal sepsis. Pediatrics. 1996;97(6 Pt 1):930; author reply-1.
140. Tierney AJ, Finer NN. Lumbar puncture in the evaluation for early neonatal sepsis. Pediatrics. 1996;97(6 Pt 1):929-30.
141. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics. 2004;113:1181-6.
142. Ray B, Mangalore J, Harikumar C, Tuladhar A. Is lumbar puncture necessary for evaluation of early neonatal sepsis?. Arch Dis Child. 2006;91:1033-5.
143. Garges HP, Moody MA, Cotten CM, Smith PB, Tiffany KF, Lenfestey R, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics. 2006;117:1094-100.
144. Mhanna MJ, Alesseh H, Gori A, Aziz HF. Cerebrospinal fluid values in very low birth weight infants with suspected sepsis at different ages. Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2008;9:294-8.
145. Kiser C, Nawab U, McKenna K, Aghai ZH. Role of guidelines on length of therapy in chorioamnionitis and neonatal sepsis. Pediatrics. 2014;133:992-8.
146. Benirschke K, Clifford SH. Intrauterine bacterial infection of the newborn infant: frozen sections of the cord as an aid to early detection. J Pediatr. 1959;54:11-8.
147. Olding L. Value of placentitis as a sign of intrauterine infection in human subjects. Acta Pathol Microbiol Scand A. 1970;78:256-64.
148. Zhang JM, Kraus FT, Aquino TI. Chorioamnionitis: a comparative histologic, bacteriologic, and clinical study. Int J Gynecol Pathol. 1985;4:1-10.
149. Svensson L, Ingemarsson I, Mardh PA. Chorioamnionitis and the isolation of microorganisms from the placenta. Obstet Gynecol. 1986;67:403-9.
150. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 1988;319:972-8.
151. Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol. 1991;165(4 Pt 1):955-61.
152. van Hoeven KH, Anyaegbunam A, Hochster H, Whitty JE, Distant J, Crawford C, et al. Clinical significance of increasing histologic severity of acute inflammation in the fetal membranes and umbilical cord. Pediatr Pathol Lab Med. 1996;16:731-44.
153. Smulian JC, Shen-Schwarz S, Vintzileos AM, Lake MF, Ananth CV. Clinical chorioamnionitis and histologic placental inflammation. Obstet Gynecol. 1999;94:1000-5.
154. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;11:18-25.
155. Rhone SA, Magee F, Remple V, Money D. The association of placental abnormalities with maternal and neonatal clinical findings: a retrospective cohort study. J Obstet Gynaecol Can. 2003;25:123-8.
156. Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation-A workshop report. Placenta. 2005;26(Suppl A):S114-7.
157. Lee SE, Romero R, Kim CJ, Shim SS, Yoon BH. Funisitis in term pregnancy is associated with microbial invasion of the amniotic cavity and intra-Amniotic inflammation. J Matern Fetal Neonatal Med. 2006;19:693-7.
158. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med. 2006;11:296-301.
159. Lee SE, Romero R, Jung H, Park CW, Park JS, Yoon BH. The intensity of the fetal inflammatory response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 2007;197:294 e1-6.
160. Seong HS, Lee SE, Kang JH, Romero R, Yoon BH. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol. 2008;199:375 e1-5.
161. Kim MJ, Romero R, Gervasi MT, Kim JS, Yoo W, Lee DC, et al. Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-Amniotic infection. Lab Invest. 2009;89:924-36.
162. Park CW, Moon KC, Park JS, Jun JK, Romero R, Yoon BH. The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-Amniotic inflammatory response is more likely and severe: clinical implications. Placenta. 2009;30:56-61.
163. Redline RW. Inflammatory response in acute chorioamnionitis. Semin Fetal Neonatal Med. 2012;17:20-5.
164. Roberts DJ, Celi AC, Riley LE, Onderdonk AB, Boyd TK, Johnson LC, et al. Acute histologic chorioamnionitis at term: nearly always noninfectious. PloS one. 2012;7:e31819.
165. Lee SM, Park JW, Kim BJ, Park CW, Park JS, Jun JK, et al. Acute histologic chorioamnionitis is a risk factor for adverse neonatal outcome in late preterm birth after preterm premature rupture of membranes. PloS one. 2013;8:e79941.
166. Park CW, Yoon BH, Kim SM, Park JS, Jun JK. Which is more important for the intensity of intra-Amniotic inflammation between total grade or involved anatomical region in preterm gestations with acute histologic chorioamnionitis?. Obstet Gynecol Sci. 2013;56:227-33.
167. Park CW, Yoon BH, Park JS, Jun JK. A fetal and an intraamniotic inflammatory response is more severe in preterm labor than in preterm PROM in the context of funisitis: unexpected observation in human gestations. PloS one. 2013;8:e62521.
168. Kim SM, Romero R, Park JW, Oh KJ, Jun JK, Yoon BH. The relationship between the intensity of intra-Amniotic inflammation and the presence and severity of acute histologic chorioamnionitis in preterm gestation. J Matern Fetal Neonatal Med. 2014:1-10. [Epub ahead of print].
169. Park CW, Kim SM, Park JS, Jun JK, Yoon BH. Fetal, amniotic and maternal inflammatory responses in early stage of ascending intrauterine infection, inflammation restricted to choriodecidua, in preterm gestation. J Matern Fetal Neonatal Med. 2014;27:98-105.
170. Murtha AP, Auten R, Herbert WN. Apoptosis in the chorion laeve of term patients with histologic chorioamnionitis. Infect Dis Obstet Gynecol. 2002;10:93-6.
171. George RB, Kalich J, Yonish B, Murtha AP. Apoptosis in the chorion of fetal membranes in preterm premature rupture of membranes. Am J Perinat. 2008;25:29-32.
172. Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis-A complex pathophysiologic syndrome. Placenta. 2010;31:113-20.
173. Conti N, Torricelli M, Voltolini C, Vannuccini S, Clifton VL, Bloise E, et al. Term histologic chorioamnionitis: a heterogeneous condition. Eur J Obstet Gynecol Reprod Biol. 2015;188:34-8.
174. Mendilcioglu I, Kilicarslan B, Gurkan Zorlu C, Karaveli S, Uner M, Trak B. Placental biopsy by frozen section: does it have a role in evaluation of fetal well-being?. Aust NZ J Obstet Gynaecol. 2003;43:433-7.
175. Beaudet L, Karuri S, Lau J, Magee F, Lee SK, von Dadelszen P. Placental pathology and clinical outcomes in a cohort of infants admitted to a neonatal intensive care unit. J Obstet Gynaecol Can. 2007;29:315-23.
176. Mahe E, Hamid J, Terry J, Jansen JW, Bourgeois J, Arredondo-Marin J. Frozen section of placental membranes and umbilical cord: an aid to early postpartum diagnosis of intra-Amniotic infection. Am J Clin Pathol. 2014;142:202-8.
177. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998;179:186-93.
178. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179:194-202.
179. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1999;181:773-9.
180. Dammann O, Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr. 2000;12:99-104.
181. Dammann O, Kuban KC, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev. 2002;8:46-50.
182. Romero R, Espinoza J, Goncalves LF, Gomez R, Medina L, Silva M, et al. Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2004;16:146-57.
183. Kim YM, Romero R, Chaiworapongsa T, Espinoza J, Mor G, Kim CJ. Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Tolllike receptors in epidermal keratinocytes. Histopathology. 2006;49:506-14.
184. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007;50:652-83.
185. Kim SK, Romero R, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Mittal P, et al. Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome. J Perinat Med. 2009;37:543-52.
186. Malaeb S, Dammann O. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol. 2009;24:1119-26.
187. Romero R, Savasan ZA, Chaiworapongsa T, Berry SM, Kusanovic JP, Hassan SS, et al. Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med. 2011;40:19-32.
188. Chaiworapongsa T, Romero R, Berry SM, Hassan SS, Yoon BH, Edwin S, et al. The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome. J Perinat Med. 2011;39:653-66.
189. Romero R, Soto E, Berry SM, Hassan SS, Kusanovic JP, Yoon BH, et al. Blood pH and gases in fetuses in preterm labor with and without systemic inflammatory response syndrome. J Matern Fetal Neonatal Med. 2012;25:1160-70.
190. Hofer N, Kothari R, Morris N, Muller W, Resch B. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol. 2013;209:542 e1-E11.
191. Kallapur SG, Presicce P, Rueda CM, Jobe AH, Chougnet CA. Fetal immune response to chorioamnionitis. Semin Reprod Med. 2014;32:56-67.
192. Sosenko IR, Kallapur SG, Nitsos I, Moss TJ, Newnham JP, Ikegami M, et al. IL-1 alpha causes lung inflammation and maturation by direct effects on preterm fetal lamb lungs. Pediatr Res. 2006;60294-8.
193. Polin RA. Systemic infection and brain injury in the preterm infant. Jornal de pediatria. 2008;84:188-91.
194. Kemp MW, Saito M, Newnham JP, Nitsos I, Okamura K, Kallapur SG. Preterm birth, infection, and inflammation advances from the study of animal models. Reprod Sci. 2010;17:619-28.
195. Kallapur SG, Kramer BW, Nitsos I, Pillow JJ, Collins JJ, Polglase GR, et al. Pulmonary and systemic inflammatory responses to intra-Amniotic IL-1alpha in fetal sheep. Am J Physiol Lung Cellular Mol Physiol. 2011;301:L285-95.
196. Wolfs TG, Kallapur SG, Polglase GR, Pillow JJ, Nitsos I, Newnham JP, et al. IL-1alpha mediated chorioamnionitis induces depletion of FoxP3+ cells and ileal inflammation in the ovine fetal gut. PloS one. 2011;6:e18355.
197. von Ehrenstein OS, Neta GI, Andrews W, Goldenberg R, Goepfert A, Zhang J. Child intellectual development in relation to cytokine levels in umbilical cord blood. Am J Epidemiol. 2012;175:1191-9.
198. O Shea TM, Allred EN, Kuban KC, Dammann O, Paneth N, Fichorova R, et al. Elevated concentrations of inflammationrelated proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. J Pediatr. 2012;160:395-401 e4.
199. Bose CL, Laughon MM, Allred EN, O Shea TM, Van Marter LJ, Ehrenkranz RA, et al. Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine. 2013;61:315-22.
200. Piantino JH, Schreiber MD, Alexander K, Hageman J. Culture negative sepsis and systemic inflammatory response syndrome in neonates. NeoReviews. 2013;14:e294.
201. Leviton A, Fichorova RN, O Shea TM, Kuban K, Paneth N, Dammann O, et al. Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res. 2013;73:362-70.
202. Martin CR, Bellomy M, Allred EN, Fichorova RN, Leviton A. Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns. Fetal Pediatr Pathol. 2013;32:222-34.
203. Kuypers E, Jellema RK, Ophelders DR, Dudink J, Nikiforou M, Wolfs TG, et al. Effects of intra-Amniotic lipopolysaccharide and maternal betamethasone on brain inflammation in fetal sheep. PloS one. 2013;8:e81644.
204. O Shea TM, Shah B, Allred EN, Fichorova RN, Kuban KC, Dammann O, et al. Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain Behav Immun. 2013;29:104-12.
205. Dammann O, Leviton A. Intermittent or sustained systemic inflammation and the preterm brain. Pediatr Res. 2014;75:376-80.
206. Kuban KC, O Shea TM, Allred EN, Paneth N, Hirtz D, Fichorova RN, et al. Systemic inflammation and cerebral palsy risk in extremely preterm infants. J Child Neurol. 2014;29:1692-8.
207. O Shea TM, Joseph RM, Kuban KC, Allred EN, Ware J, Coster T, et al. Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants. Pediatr Res. 2014;75:781-7.
208. Kuban KC, O Shea TM, Allred EN, Fichorova RN, Heeren T, Paneth N, et al. The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns. Pediatr Neurol. 2015;52:42-8.
209. Chiesa C, Pacifico L, Natale F, Hofer N, Osborn JF, Resch B. Fetal and early neonatal interleukin-6 response. Cytokine. 2015. [Epub ahead of print].
210. DiGiulio DB, Gervasi MT, Romero R, Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, et al. Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-Age fetuses. J Perinat Med. 2010;38:495-502.
211. Madan I, Romero R, Kusanovic JP, Mittal P, Chaiworapongsa T, Dong Z, et al. The frequency and clinical significance of intra-Amniotic infection and/or inflammation in women with placenta previa and vaginal bleeding: an unexpected observation. J Perinat Med. 2010;38:275-9.
212. Cruciani L, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Mazaki-Tovi S, et al. Pentraxin 3 in amniotic fluid: a novel association with intra-Amniotic infection and inflammation. J Perinat Med. 2010;38:161-71.
213. Gervasi MT, Romero R, Bracalente G, Erez O, Dong Z, Hassan SS, et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-Amniotic inflammation and associations with spontaneous early ( ?32 weeks) preterm delivery. J Perinat Med. 2012;40:329-43.
214. Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-Amniotic infection. Obstet Gynecol. 1988;72:823-8.
215. Chaiworapongsa T, Romero R, Kim JC, Kim YM, Blackwell SC, Yoon BH, et al. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol. 2002;186:1178-82.
216. Madsen-Bouterse SA, Romero R, Tarca AL, Kusanovic JP, Espinoza J, Kim CJ, et al. The transcriptome of the fetal inflammatory response syndrome. American journal of reproductive immunology. 2010;63:73-92.
217. Vaisbuch E, Romero R, Gomez R, Kusanovic JP, Mazaki-Tovi S, Chaiworapongsa T, et al. An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: implications for the understanding of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2011;24:391-6.
218. Park JS, Romero R, Yoon BH, Moon JB, Oh SY, Han SY, et al. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol. 2001;185:1156-61.
219. Yoon BH, Romero R, Shim JY, Shim SS, Kim CJ, Jun JK. C-reactive protein in umbilical cord blood: a simple and widely available clinical method to assess the risk of amniotic fluid infection and funisitis. J Matern Fetal Neonatal Med. 2003;14:85-90.
220. Park CW, Lee SM, Park JS, Jun JK, Romero R, Yoon BH. The antenatal identification of funisitis with a rapid MMP-8 bedside test. J Perinat Med. 2008;36:497-502.
221. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol. 1991;165(4 Pt 1):813-20.
222. Cherouny PH, Pankuch GA, Romero R, Botti JJ, Kuhn DC, Demers LM, et al. Neutrophil attractant/activating peptide-1/ interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol. 1993;169:1299-303.
223. Hsu CD, Meaddough E, Aversa K, Hong SF, Lu LC, Jones DC, et al. Elevated amniotic fluid levels of leukemia inhibitory factor, interleukin 6, and interleukin 8 in intra-Amniotic infection. Am J Obstet Gynecol. 1998;179:1267-70.
224. Ghezzi F, Gomez R, Romero R, Yoon BH, Edwin SS, David C, et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol. 1998;78:5-10.
225. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med. 2005;18:241-7.
226. Yoneda S, Sakai M, Sasaki Y, Shiozaki A, Hidaka T, Saito S. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes. J Obstet Gynaecol Res. 2007;33:38-44.
227. Jacobsson B, Mattsby-Baltzer I, Hagberg H. Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. BJOG: Int J Obstet Gynaec. 2005;112:719-24.
228. Kacerovsky M, Drahosova M, Hornychova H, Pliskova L, Bolehovska R, Forstl M, et al. Value of amniotic fluid interleukin-8 for the prediction of histological chorioamnionitis in preterm premature rupture of membranes. Neuro Endocrinol Lett. 2009;30:733-8.
229. Keelan JA, Yang J, Romero RJ, Chaiworapongsa T, Marvin KW, Sato TA, et al. Epithelial cell-Derived neutrophil-Activating peptide-78 is present in fetal membranes and amniotic fluid at increased concentrations with intra-Amniotic infection and preterm delivery. Biol Reprod. 2004;70:253-9.
230. Nhan-Chang CL, Romero R, Kusanovic JP, Gotsch F, Edwin SS, Erez O, et al. A role for CXCL13 (BCA-1) in pregnancy and intraamniotic infection/inflammation. J Matern Fetal Neonatal Med. 2008;21:763-75.
231. Romero R, Quintero R, Emamian M, Wan M, Grzyboski C, Hobbins JC, et al. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-Amniotic infection and preterm labor. Am J Obstet Gynecol. 1987;157:1454-60.
232. Hamill N, Romero R, Gotsch F, Kusanovic JP, Edwin S, Erez O, et al. Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection. J Perinat Med. 2008;36:217-27.
233. Mittal P, Romero R, Kusanovic JP, Edwin SS, Gotsch F, Mazaki-Tovi S, et al. CXCL6 (granulocyte chemotactic protein-2): a novel chemokine involved in the innate immune response of the amniotic cavity. Am J Reprod Immunol. 2008;60:246-57.
234. Romero R, Salafia CM, Athanassiadis AP, Hanaoka S, Mazor M, Sepulveda W, et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol. 1992;166:1382-8.
235. Park HS, Romero R, Lee SM, Park CW, Jun JK, Yoon BH. Histologic chorioamnionitis is more common after spontaneous labor than after induced labor at term. Placenta. 2010;31:792-5.
236. Lee SM, Lee KA, Kim SM, Park CW, Yoon BH. The risk of intraamniotic infection, inflammation and histologic chorioamnionitis in term pregnant women with intact membranes and labor. Placenta. 2011;32:516-21.
237. Mi Lee S, Romero R, Lee KA, Jin Yang H, Joon Oh K, Park CW, et al. The frequency and risk factors of funisitis and histologic chorioamnionitis in pregnant women at term who delivered after the spontaneous onset of labor. J Matern Fetal Neonatal Med. 2011;24:37-42.
238. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 1993;81:941-8.
239. Kim CJ, Yoon BH, Park SS, Kim MH, Chi JG. Acute funisitis of preterm but not term placentas is associated with severe fetal inflammatory response. Hum Pathol. 2001;32:623-9.
240. Rogers BB, Alexander JM, Head J, McIntire D, Leveno KJ. Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age. Hum Pathol. 2002;33:335-40.
241. Lee J, Oh KJ, Park CW, Park JS, Jun JK, Yoon BH. The presence of funisitis is associated with a decreased risk for the development of neonatal respiratory distress syndrome. Placenta. 2011;32:235-40.
242. Gugino LJ, Buerger PT, Wactawski-Wende J, Fisher J. Chorioamnionitis: the association between clinical and histological diagnosis. Primary Care Update Ob/Gyns. 1998;5:148.
243. Kim CJ, Yoon BH, Park SH, Chi JG. Histotopographic distribution of placental inflammation: analysis of 22 cases. J Korean Med Sci. 1998;13:519-24.
244. Oh KJ, Park KH, Kim SN, Jeong EH, Lee SY, Yoon HY. Predictive value of intra-Amniotic and serum markers for inflammatory lesions of preterm placenta. Placenta. 2011;32:732-6.
245. Erdemir G, Kultursay N, Calkavur S, Zekioglu O, Koroglu OA, Cakmak B, et al. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol. 2013;54:267-74.
246. Park CW, Yoon BH, Kim SM, Park JS, Jun JK. The frequency and clinical significance of intra-Amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell counts. Obstet Gynecol Sci. 2013;56:167-75.
247. Keenan WJ, Steichen JJ, Mahmood K, Altshuler G. Placental pathology compared with clinical outcome: a retrospective blind review. Am J Dis Child. 1977;131:1224-7.
248. Russell P. Inflammatory lesions of the human placenta, I: clinical significance of acute chorioamnionitis. Am J Diagn Gynecol Obstet. 1979;1:127-37.
249. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol. 1997;89:265-71.
250. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13:102-9.
251. Dempsey E, Chen MF, Kokottis T, Vallerand D, Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. 2005;22:155-9.
252. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23-to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006;195:803-8.
253. Veleminsky M, Jr., Pradna J, Veleminsky M, Sr., Tosner J. Relationship of amniotic-Type placenta inflammation to pPROM, PROM and risk of early onset neonatal sepsis. Neuro Endocrinol Lett. 2008;29:447-50.
254. Moscuzza F, Belcari F, Nardini V, Bartoli A, Domenici C, Cuttano A, et al. Correlation between placental histopathology and fetal/neonatal outcome: chorioamnionitis and funisitis are associated to intraventricular haemorrage and retinopathy of prematurity in preterm newborns. Gynecol Endocrinol: Official J International Society of Gynecological Endocrinology. 2011;27:319v23.
255. Tsiartas P, Kacerovsky M, Musilova I, Hornychova H, Cobo T, Savman K, et al. The association between histological chorioamnionitis, funisitis and neonatal outcome in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2013;26:1332-6.
256. Arayici S, Kadioglu Simsek G, Oncel MY, Eras Z, Canpolat FE, Oguz SS, et al. The effect of histological chorioamnionitis on the short-Term outcome of preterm infants =32 weeks: a single-center study. J Matern Fetal Neonatal Med. 2014 27 1129-33
257. St Geme JW, Jr., Murray DL, Carter J, Hobel CJ, Leake RD, Anthony BF, et al. Perinatal bacterial infection after prolonged rupture of amniotic membranes: an analysis of risk and management. J Pediatr. 1984;104:608-13.
258. Hoang D, Charlagorla P, Salafia C, VanHorn S, Dygulska B, Narula P, et al. Histologic chorioamnionitis as a consideration in the management of newborns of febrile mothers. J Matern Fetal Neonatal Med. 2013;26:828-32.
259. Cuna A, Hakima L, Tseng YA, Fornier B, Islam S, Quintos-Alagheband ML, et al. Clinical dilemma of positive histologic chorioamnionitis in term newborn. Front Pediatr. 2014;2:27.
260. Overbach AM, Daniel SJ, Cassady G. The value of umbilical cord histology in the management of potential perinatal infection. J Pediatr. 1970;76:22-31.
261. Cassell GH, Davis RO, Waites KB, Brown MB, Marriott PA, Stagno S, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis. 1983;10(Suppl 4):294-302.
262. Gray DJ, Robinson HB, Malone J, Thomson RB, Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn. 1992;12:111-7.
263. Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med. 1995;40:375-9.
264. McCracken GH, Jr., Shinefield HR. Changes in the pattern of neonatal septicemia and meningitis. Am J Dis Child. 1966;112:33-9.
265. Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol. 1992;79:75-80.
266. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. J Am Med Assoc. 2004;292:2357-65.
267. Roman J, Fernandez F, Velasco F, Rojas R, Roldan MR, Torres A. Serum TNF levels in neonatal sepsis and septic shock. Acta Paediatrica. 1993;82:352-4.
268. Atici A, Satar M, Cetiner S, Yaman A. Serum tumor necrosis factor-Alpha in neonatal sepsis. Am J Perinatol. 1997;14:401-4.
269. Stout MJ, Conlon B, Landeau M, Lee I, Bower C, Zhao Q, et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol. 2013;208:226 e1-7.
270. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation, Nat Rev Immunol.2013 13, 159-175.